All sites C00-96,D32-33,D42-43,D45-47,D76 1452 90.5 1.5 3.6 1.0 3.4
Mouth, pharynx C00-14 34 98.2 - 1.2 0.6 -
  Lip C00 7 97.0 - 3.0 - -
  Tongue C02 5 96.0 - - 4.0 -
  Mouth, other C03-06 8 100.0 - - - -
  Salivary glands C07-08 3 100.0 - - - -
  Pharynx C01,C09-14 11 98.2 - 1.8 - -
Digestive organs C15-26 283 82.7 0.8 9.7 1.8 5.0
  Oesophagus C15 21 93.3 - 3.8 1.0 1.9
  Stomach C16 34 94.8 - 2.9 - 2.3
  Small intestine C17 5 96.3 - 3.7 - -
  Colon C18 86 95.1 - 1.2 0.9 2.8
  Rectum, rectosigmoid C19-20 51 96.8 - 1.2 0.8 1.2
  Anus C21 2 100.0 - - - -
  Liver C22 25 72.6 0.8 16.1 4.8 5.6
  Gallbladder, bile ducts C23-24 10 49.0 2.0 29.4 9.8 9.8
  Pancreas C25 46 43.0 3.5 35.7 3.0 14.8
  Other digestive organs C26 3 50.0 6.3 12.5 6.3 25.0
Respiratory organs C30-39 164 80.1 6.7 7.1 1.1 5.0
  Nose, sinuses C30-31 3 100.0 - - - -
  Larynx, epiglottis C32 9 100.0 - - - -
  Lung, trachea C33-34 151 78.7 7.3 7.7 1.2 5.2
  Mediastinum, pleura C38 1 83.3 - - - 16.7
Bone C40-41 3 100.0 - - - -
Melanoma of the skin C43 65 100.0 - - - -
Skin, non-melanoma C44 77 99.7 0.3 - - -
Mesothelioma C45 14 98.6 1.4 - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 8 100.0 - - - -
Breast C50 3 100.0 - - - -
Male genital organs C60-63 464 97.9 0.1 0.3 0.6 1.2
  Prostate C61 446 97.8 0.1 0.3 0.6 1.3
  Testis C62 14 100.0 - - - -
  Other male genital C60,C63 4 100.0 - - - -
Urinary organs C64-68 131 94.2 - 3.1 0.5 2.3
  Kidney C64 49 87.7 - 6.1 0.8 5.3
  Bladder and urinary tract2 C65-68 82 98.1 - 1.2 0.2 0.5
Eye C69 2 63.6 9.1 18.2 - 9.1
Brain, central nervous system C70-72,D32-33,D42-43 38 87.2 - 5.3 2.1 5.3
Thyroid gland C73 9 95.6 4.4 - - -
Other endocrine glands C74-75 2 77.8 - - - 22.2
Illdefined or unknown C76,C80 25 55.6 3.2 17.5 7.1 16.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 130 84.4 4.5 0.9 1.7 8.5
  Hodgkin lymphoma C81 6 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 60 99.0 0.3 - - 0.7
  Malignant immunoproliferative diseases C88 3 69.2 - - - 30.8
  Myeloma and other plasma cell tumors C90 17 77.9 3.5 5.8 3.5 9.3
  Leukaemia C91-95 29 71.9 12.3 - 1.4 14.4
  Myelodysplastic syndromes D46 6 21.4 7.1 3.6 10.7 57.1
  Myeloproliferaitive neoplasms D45,D47 10 75.5 10.2 - 6.1 8.2
Not included above
  Basal cell carcinoma of the skin 392 99.9 - - 0.1 -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.